Doebele, R. C., Drilon, A., Paz-Ares, L., Siena, S., Shaw, A. T., Farago, A. F., . . . Demetri, G. D. (2019). Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: Integrated analysis of three phase 1–2 trials. Lancet Oncol.
Chicago Style CitationDoebele, Robert C., et al. "Entrectinib in Patients With Advanced or Metastatic NTRK Fusion-positive Solid Tumours: Integrated Analysis of Three Phase 1–2 Trials." Lancet Oncol 2019.
Cita MLADoebele, Robert C., et al. "Entrectinib in Patients With Advanced or Metastatic NTRK Fusion-positive Solid Tumours: Integrated Analysis of Three Phase 1–2 Trials." Lancet Oncol 2019.
Atenció: Aquestes cites poden no estar 100% correctes.